Private Advisor Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Private Advisor Group’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-85,100	Closed	-$37K	–	2177
2022 Q2	$37K	Hold	85,100	–	–	﹤0.01%	2035
2022 Q1	$107K	Hold	85,100	–	–	﹤0.01%	1989
2021 Q4	$111K	Sell	85,100 -85,100	-50%	-$136K	﹤0.01%	2008
2021 Q3	$350K	Buy	170,200 +139,100	+447%	+$247K	﹤0.01%	1659
2021 Q2	$49K	Hold	31,100	–	–	﹤0.01%	1936
2021 Q1	$69K	Hold	31,100	–	–	﹤0.01%	1832
2020 Q4	$77K	Hold	31,100	–	–	﹤0.01%	1706
2020 Q3	$110K	Hold	31,100	–	–	﹤0.01%	1484
2020 Q2	$110K	Hold	31,100	–	–	﹤0.01%	1656
2020 Q1	$73K	Sell	31,100 -6,650	-18%	-$18.7K	﹤0.01%	1347
2019 Q4	$83K	Hold	37,750	–	–	﹤0.01%	1568
2019 Q3	$75K	Hold	37,750	–	–	﹤0.01%	1595
2019 Q2	$55K	Buy	+37,750	New	+$66K	﹤0.01%	1620
2019 Q1	–	Sell	-37,750	Closed	-$49K	–	1619
2018 Q4	$49K	Buy	+37,750	New	+$69.1K	﹤0.01%	1322

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Private Advisor Group's NYMX Position: Q3 2022 in Review

Private Advisor Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2022, closing a stake of 85,100 shares — an estimated $37K sold.

Private Advisor Group first reported a position in NYMX in Q4 2018 and held it in 14 quarters. The position peaked at $350K in Q3 2021. 34 funds tracked by Wall St. Rank hold NYMX as of Q3 2022.

Private Advisor Group reported no remaining Nymox Pharmaceutical Corp position as of Q3 2022 after selling out during the quarter.
Private Advisor Group sold 85,100 Nymox Pharmaceutical Corp shares in Q3 2022, an estimated $37K.
Private Advisor Group first reported a position in Nymox Pharmaceutical Corp in Q4 2018 and held it in 14 quarters.
Private Advisor Group's Nymox Pharmaceutical Corp position peaked at $350K in Q3 2021.
34 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.